Ballad - Insulin Pen Concept
Insulin Pen for Partially Sighted Diabetics
The Ballad smart insulin pen empowers visually impaired diabetics to self-administer insulin with ease and confidence. It enhances user intuition with high contrast touch-points, a connected app featuring a 600% dose unit display increase, and replaceable medication cartridges that reduce plastic waste. By leveraging the high-resolution display integrated into smartphones today, Ballad simplifies the user experience and promotes independent diabetes management. By maximizing visibility of information on the app the critical challenges faced by partially sighted diabetics are resolved without the need for on-device technology integration.
Client / Manufacturer
Design
Cambridge Consultants
Cambridge, GBCambridge Consultants
Cambridge, GBHarry Moorman, Chris Harm, Ben Cullis Watson, Pierre-Francois Gautier, Sam EckleyDate of Launch
2023
Development Time
up to 6 Month
Target Regions
Asia, Australia / Oceania, Europe, North America
Target Groups
Consumers / Users, Trade / Industry